Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.

Source:http://linkedlifedata.com/resource/pubmed/id/18845996

Download in:

View as

General Info

PMID
18845996